Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Hematology

Subtypes and Underlying Causes: The 'Why' Behind the Attack

At a Glance

Evans syndrome may occur on its own or alongside another immune, autoimmune, genetic, or blood disorder. Finding the underlying cause and whether red-cell destruction is warm or cold helps doctors choose testing, monitoring, and treatment.

Evans syndrome is not a single disease with a single cause. Instead, it is a clinical “umbrella” that describes a specific pattern of immune behavior. To provide the best care, doctors must determine whether the syndrome is standing alone or if it is a sign of a broader health issue. This process involves classifying the disease into subtypes and looking for associated conditions or genetic links.

Primary vs. Secondary Evans Syndrome

The first major distinction your doctor will make is whether the condition is primary or secondary.

  • Primary (Idiopathic) Evans Syndrome: This is diagnosed when the immune system attacks red blood cells and platelets, but no other underlying disease can be found [1]. About 50% to 75% of adult cases are initially classified as primary [2][3].
  • Secondary Evans Syndrome: This occurs when the blood disorder is triggered by or happens alongside another condition. It is important to identify these “secondary” causes because treating the underlying issue is often the key to managing the blood counts [4][5].

Warm vs. Cold AIHA: Why the Temperature Matters

In Evans syndrome, the “anemia” part (Autoimmune Hemolytic Anemia) is usually the warm type, but knowing the difference is critical for treatment success.

  • Warm AIHA: This is the most common form. The immune system creates IgG antibodies that attack red blood cells at normal body temperature [6]. These cells are typically destroyed in the spleen. This type usually responds well to steroids [7][8].
  • Cold-Antibody Hemolysis: This is rarer in classic Evans syndrome. It involves antibodies (often IgM) that become active at cooler temperatures [6]. It is important not to confuse this entirely with Cold Agglutinin Disease (CAD), which is a specific clonal disorder. Steroids are generally not effective for cold-type hemolysis; instead, doctors may use targeted treatments [9][10].

Pediatric Evans Syndrome and Genetics

In children, Evans syndrome can sometimes be a “red flag” for an Inborn Error of Immunity (IEI)—a genetic condition altering how the immune system is built [11].

In specialized referral studies, up to 65% of tested children with complex Evans syndrome were found to have an underlying genetic mutation [12]. Common genetic markers include:

  • ALPS (Autoimmune Lymphoproliferative Syndrome): Often caused by mutations in the FAS gene, leading to an “overcrowded” immune system [4][12].
  • CTLA4 and LRBA Defects: These mutations impair the “brakes” of the immune system, allowing it to attack the body uncontrollably [13][12].
  • STAT3 Mutations: These can cause the immune system to become hyper-active [14].

Because of these strong links, pediatric experts often recommend that children with Evans syndrome—especially those with persistent disease, unusual lymphoproliferation, or early onset—see an immunologist for genetic screening [15].

Adult Associated Conditions

In adults, Evans syndrome is less likely to be purely genetic and more likely to be associated with other chronic illnesses:

  • Systemic Lupus Erythematosus (SLE): A widespread autoimmune disease that frequently occurs with Evans syndrome [4][16].
  • Hematologic Malignancies: Certain blood cancers, such as Chronic Lymphocytic Leukemia (CLL) or Hodgkin Lymphoma, can cause the immune system to misfire and attack healthy cells [17][18].
  • Common Variable Immunodeficiency (CVID): A condition where the body doesn’t produce enough protective antibodies, paradoxically making it more likely to produce “bad” autoantibodies [4][19].

The Importance of Ongoing Monitoring

Evans syndrome can be “dynamic.” A person may start with a diagnosis of Primary Evans syndrome, only to have a secondary condition—like Lupus or an immune deficiency—become clear years later [20][3]. Regular follow-ups are essential not just to check blood counts, but to watch for new symptoms that might change how the disease is classified and treated.

Common questions in this guide

What is the difference between primary and secondary Evans syndrome?
Primary Evans syndrome is diagnosed when the immune system attacks red blood cells and platelets but doctors do not find another underlying disease. Secondary Evans syndrome occurs alongside another condition, such as lupus, a blood cancer, or an immune deficiency, and treating that condition may help manage the blood counts.
Is the anemia in Evans syndrome usually warm or cold?
The anemia component of Evans syndrome is usually warm autoimmune hemolytic anemia, in which IgG antibodies attack red blood cells at normal body temperature; it often responds to steroids. Cold-antibody hemolysis is less common, and steroids generally do not work well for it, so doctors may consider targeted treatment.
Should a child with Evans syndrome have genetic testing?
A child with persistent, early-onset, or complex Evans syndrome, especially with unusual lymph node or immune-cell enlargement or recurring infections, may need evaluation by a pediatric immunologist. The specialist can determine whether genetic testing for an inborn immune disorder is appropriate.
What conditions can occur with Evans syndrome in adults?
Adult Evans syndrome may be associated with systemic lupus erythematosus, chronic lymphocytic leukemia, Hodgkin lymphoma, or common variable immunodeficiency. These conditions may not always be apparent at the first diagnosis, so ongoing follow-up can be important.
Can Evans syndrome change from primary to secondary?
Yes. A person may initially be considered to have primary Evans syndrome because no associated condition is known, and an autoimmune disease or immune deficiency may become clear years later. New findings can change how the syndrome is classified and treated.
What symptoms or history should I tell my Evans syndrome doctor about?
Tell your doctor about recurring infections, such as frequent sinus infections or pneumonia, and any finger pain or color changes triggered by cold exposure. A family history of autoimmune or immune problems and recently started medicines may also be important to discuss.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Evans syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my (or my child's) Evans syndrome currently classified as 'primary' or 'secondary' to another condition?
  2. 2.For a child: Does the history of symptoms or infections suggest we should see an immunologist for genetic testing?
  3. 3.For an adult: Have we ruled out associated conditions like lupus or chronic lymphocytic leukemia (CLL)?
  4. 4.Is the hemolytic anemia component 'warm' or 'cold,' and how does that specific type change our choice of medication?
  5. 5.Since Evans syndrome can evolve, how often will we re-screen for other autoimmune or blood disorders?

References

References (20)
  1. 1

    Adult Evans' Syndrome.

    Michel M

    Hematology/oncology clinics of North America 2022; (36(2)):381-392 doi:10.1016/j.hoc.2021.12.004.

    PMID: 35282950
  2. 2

    Evans syndrome in adults: an observational multicenter study.

    Fattizzo B, Michel M, Giannotta JA, et al.

    Blood advances 2021; (5(24)):5468-5478 doi:10.1182/bloodadvances.2021005610.

    PMID: 34592758
  3. 3

    Evans syndrome in adults - incidence, prevalence, and survival in a nationwide cohort.

    Hansen DL, Möller S, Andersen K, et al.

    American journal of hematology 2019; (94(10)):1081-1090 doi:10.1002/ajh.25574.

    PMID: 31292991
  4. 4

    New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination.

    Hidaka D, Ogasawara R, Sugimura S, et al.

    International journal of hematology 2022; (115(3)):424-427 doi:10.1007/s12185-021-03243-2.

    PMID: 34687421
  5. 5

    Diagnosis and management of Evans syndrome in adults: first consensus recommendations.

    Fattizzo B, Marchetti M, Michel M, et al.

    The Lancet. Haematology 2024; (11(8)):e617-e628 doi:10.1016/S2352-3026(24)00144-3.

    PMID: 38968944
  6. 6

    Autoimmune Hemolytic Anemias: Challenges in Diagnosis and Therapy.

    Barcellini W, Fattizzo B

    Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2024; (51(5)):321-331 doi:10.1159/000540475.

    PMID: 39371250
  7. 7

    Warm autoimmune hemolytic anemia.

    Naik R

    Hematology/oncology clinics of North America 2015; (29(3)):445-53.

    PMID: 26043384
  8. 8

    The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?

    Berentsen S, Fattizzo B, Barcellini W

    Frontiers in immunology 2023; (14()):1180509 doi:10.3389/fimmu.2023.1180509.

    PMID: 37168855
  9. 9

    Cold agglutinin disease: pathophysiology, diagnosis, and the evolving therapeutic landscape.

    Choi DH

    Blood research 2026; (61(1)).

    PMID: 42696222
  10. 10

    New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.

    Berentsen S

    Frontiers in immunology 2020; (11()):590 doi:10.3389/fimmu.2020.00590.

    PMID: 32318071
  11. 11

    Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort.

    Westermann-Clark E, Meehan CA, Meyer AK, et al.

    Frontiers in immunology 2021; (12()):649182 doi:10.3389/fimmu.2021.649182.

    PMID: 33968040
  12. 12

    Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes.

    Hadjadj J, Aladjidi N, Fernandes H, et al.

    Blood 2019; (134(1)):9-21 doi:10.1182/blood-2018-11-887141.

    PMID: 30940614
  13. 13

    Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations.

    Besnard C, Levy E, Aladjidi N, et al.

    Clinical immunology (Orlando, Fla.) 2018; (188()):52-57 doi:10.1016/j.clim.2017.12.009.

    PMID: 29330115
  14. 14

    Prolonged Severe CD4+ Lymphocytopenia and Hypogammaglobulinemia in Patients With Evans' Syndrome: A Case Report.

    Kurokawa T, Imoto N, Muramatsu H, Shingo K

    Cureus 2024; (16(12)):e75283 doi:10.7759/cureus.75283.

    PMID: 39764316
  15. 15

    Consensus of the Italian Primary Immunodeficiency Network on the use and interpretation of genetic testing for diagnosing inborn errors of immunity.

    Giardino G, Di Matteo G, Giliani S, et al.

    The Journal of allergy and clinical immunology 2025; (155(4)):1149-1160 doi:10.1016/j.jaci.2024.11.030.

    PMID: 39622296
  16. 16

    Evans syndrome as a presentation in systemic lupus erythematous, coexisting with Hashimoto's thyroiditis and pernicious anemia: a case report.

    Mansour M, Shamasnah A, Alsaadi D, et al.

    Journal of medical case reports 2024; (18(1)):643 doi:10.1186/s13256-024-05002-3.

    PMID: 39732732
  17. 17

    Successful Treatment of Evans Syndrome Onset With Zanubrutinib in Combination With Romiplostim During Venetoclax Treatment in a Patient With Chronic Lymphocytic Leukemia: A Case Report.

    Innao V, Barbagallo APM, Bianco O, et al.

    Clinical case reports 2026; (14()):e72697 doi:10.1002/ccr3.72697.

    PMID: 42164027
  18. 18

    A rare paraneoplastic condition in Hodgkin lymphoma: Evans syndrome and literature review.

    Atas U, Cerci K, Tuncer S, Karakus V

    Northern clinics of Istanbul 2024; (11(5)):488-491 doi:10.14744/nci.2022.66742.

    PMID: 39431027
  19. 19

    Immune cytopenias as a continuum in inborn errors of immunity: An in-depth clinical and immunological exploration.

    Zama D, Conti F, Moratti M, et al.

    Immunity, inflammation and disease 2021; (9(2)):583-594 doi:10.1002/iid3.420.

    PMID: 33838017
  20. 20

    Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort.

    Aladjidi N, Fernandes H, Leblanc T, et al.

    Frontiers in pediatrics 2015; (3()):79 doi:10.3389/fped.2015.00079.

    PMID: 26484337

This page is for informational purposes only and does not constitute medical advice. It explains Evans syndrome subtypes and associated conditions; ask your hematologist or immunologist about your or your child's evaluation.